Long-term community studies to evaluate and improve primary health care programmes in Guinea-Bissau
Info
Start date: 31 December, 2006 End date: 30 December, 2012 Project type: Larger strategic projects - ENRECA (prior to 2008) Project code: 502-SSI2 Countries: Guinea-Bissau Thematic areas: Health, Lead institution: Statens Serum Institut (SSI), Denmark Policy Brief: Policy Brief Project coordinator: Peter Aaby Total grant: 12,939,627 DKK Project files:
Policy-brief_502-SSI2_Peter-AabyProject summary
Strengthening research capacity in Guinea-Bissau by completing 5 initiated PhDs
and 2 new post-doc, 2 PhD and 2 MSc studies and conducting trials to optimise
health interventions. Studies deal with control and treatment of malaria, measles,
HIV, TB and non-targeted effects of health interventions
Outputs
Project Completion Report:
During the ENRECA-III phase five (5) Guinean have defended their theses and the thesis of the last candidate has had her thesis accepted for defence. The Danish trained PhD students in Bissau have become the backbone for the new National Institute of Health (INASA) which was officially opened in 2011.
40 papers have been published in 2012 and many have received attention in the form of commentaries or editorials, reflecting that there is an increasing interest in our research on the non-specific effects of interventions.
The research in Bissau is continuing to produce very remarkable results on the effects of immune stinrulation. The first studies documenting immunologicai mechanism explaining the non-specific effects are beginning to appear. We have received major grants to continue the work on non-specific effects from EU, DANIDA-Novo, and DNRF. We are now also able to show similar non-specific effects in Denmark.
WHO's immunisation programme has started a review of the non-specific effects of vaccines.
